dr inż. Agnieszka Basińska-Ziobroń

dr inż. Agnieszka Basińska-Ziobroń

+48 12 6623389
pokój 309
Zakład Farmakokinetyki i Metabolizmu Leków

Dokonania naukowe

  • Publikacje

The impact of noradrenergic neurotoxin DSP-4 and noradrenaline transporter knockout (NET-KO) on the activity of liver cytochrome P450 3A (CYP3A) in male and female mice

Autorzy: Agnieszka Basińska-Ziobroń

DOI: 10.1007/s43440-022-00406-8
Date: 2022-10-01

Levomepromazine and clozapine induce the main human cytochrome P450 drug metabolizing enzyme CYP3A4

Autorzy:

DOI: 10.1007/s43440-020-00157-4
Date: 2021-02-01

In vitro inhibition of human cytochrome P450 enzymes by the novel atypical antipsychotic drug asenapine: a prediction of possible drug–drug interactions

Autorzy:

DOI: 10.1007/s43440-020-00089-z
Date: 2020-06-01

<i>N</i>1-Azinylsulfonyl-1<i>H</i>-indoles: 5-HT6 Receptor Antagonists with Procognitive and Antidepressant-Like Properties

Autorzy:

DOI: 10.1021/acsmedchemlett.6b00056
Date: 2016-06-09

Inhibition of human cytochrome P450 isoenzymes by a phenothiazine neuroleptic levomepromazine: An in vitro study

Autorzy:

DOI: 10.1016/j.pharep.2015.04.005
Date: 2015-12-01

The influence of amitriptyline and carbamazepine on levomepromazine metabolism in human liver: An in vitro study

Autorzy:

DOI: 10.1016/j.pharep.2014.07.012
Date: 2014-12-01

The cytochrome P450-catalyzed metabolism of levomepromazine: a phenothiazine neuroleptic with a wide spectrum of clinical application

Autorzy:

DOI: 10.1016/j.bcp.2014.05.005
Date: 2014-07-01

Zobacz także